140 related articles for article (PubMed ID: 20005459)
21. [Initial experience of proton beam therapy at the new facility of the University of Tsukuba].
Kagei K; Tokuuye K; Sugahara S; Hata M; Igaki H; Hashimoto T; Ohara K; Akine Y
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 May; 64(4):225-30. PubMed ID: 15211886
[TBL] [Abstract][Full Text] [Related]
22. [Initial clinical experience of proton therapy at Shizuoka Cancer Center].
Murayama S; Fuji H; Yamashita H; Futami Y; Numano M; Harada H; Kamata M; Nishimura T
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):424-31. PubMed ID: 16334397
[TBL] [Abstract][Full Text] [Related]
23. Isocenter characteristics of an external ring proton gantry.
Moyers MF; Lesyna W
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1622-30. PubMed ID: 15590194
[TBL] [Abstract][Full Text] [Related]
24. Introducing an on-line adaptive procedure for prostate image guided intensity modulate proton therapy.
Zhang M; Westerly DC; Mackie TR
Phys Med Biol; 2011 Aug; 56(15):4947-65. PubMed ID: 21772078
[TBL] [Abstract][Full Text] [Related]
25. Effect of anatomic motion on proton therapy dose distributions in prostate cancer treatment.
Zhang X; Dong L; Lee AK; Cox JD; Kuban DA; Zhu RX; Wang X; Li Y; Newhauser WD; Gillin M; Mohan R
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):620-9. PubMed ID: 17236979
[TBL] [Abstract][Full Text] [Related]
26. Beam-on imaging of short-lived positron emitters during proton therapy.
Buitenhuis HJT; Diblen F; Brzezinski KW; Brandenburg S; Dendooven P
Phys Med Biol; 2017 Jun; 62(12):4654-4672. PubMed ID: 28379155
[TBL] [Abstract][Full Text] [Related]
27. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
28. Experimental validation of the filtering approach for dose monitoring in proton therapy at low energy.
Attanasi F; Belcari N; Camarda M; Del Guerra A; Moehrs S; Rosso V; Vecchio S; Lanconelli N; Cirrone GA; Di Rosa F; Russo G
Phys Med; 2008 Jun; 24(2):102-6. PubMed ID: 18411070
[TBL] [Abstract][Full Text] [Related]
29. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
30. The impact of uncertainties in the CT conversion algorithm when predicting proton beam ranges in patients from dose and PET-activity distributions.
España S; Paganetti H
Phys Med Biol; 2010 Dec; 55(24):7557-71. PubMed ID: 21098912
[TBL] [Abstract][Full Text] [Related]
31. Commissioning and initial experience with the first clinical gantry-mounted proton therapy system.
Zhao T; Sun B; Grantham K; Rankine L; Cai B; Goddu SM; Santanam L; Knutson N; Zhang T; Reilly M; Bottani B; Bradley J; Mutic S; Klein EE
J Appl Clin Med Phys; 2016 Mar; 17(2):24-40. PubMed ID: 27074470
[TBL] [Abstract][Full Text] [Related]
32. Development of dose delivery verification by PET imaging of photonuclear reactions following high energy photon therapy.
Janek S; Svensson R; Jonsson C; Brahme A
Phys Med Biol; 2006 Nov; 51(22):5769-83. PubMed ID: 17068364
[TBL] [Abstract][Full Text] [Related]
33. Comparison of plan quality provided by intensity-modulated arc therapy and helical tomotherapy.
Cao D; Holmes TW; Afghan MK; Shepard DM
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):240-50. PubMed ID: 17707278
[TBL] [Abstract][Full Text] [Related]
34. Short-lived positron emitters in beam-on PET imaging during proton therapy.
Dendooven P; Buitenhuis HJ; Diblen F; Heeres PN; Biegun AK; Fiedler F; van Goethem MJ; van der Graaf ER; Brandenburg S
Phys Med Biol; 2015 Dec; 60(23):8923-47. PubMed ID: 26539812
[TBL] [Abstract][Full Text] [Related]
35. Distributions of beta+ decayed nuclei generated in the CH2 and H2O targets by the target nuclear fragment reaction using therapeutic MONO and SOBP proton beam.
Nishio T; Sato T; Kitamura H; Murakami K; Ogino T
Med Phys; 2005 Apr; 32(4):1070-82. PubMed ID: 15895592
[TBL] [Abstract][Full Text] [Related]
36. Clinical consequences of relative biological effectiveness variations in proton radiotherapy of the prostate, brain and liver.
Carabe A; España S; Grassberger C; Paganetti H
Phys Med Biol; 2013 Apr; 58(7):2103-17. PubMed ID: 23470339
[TBL] [Abstract][Full Text] [Related]
37. How costly is particle therapy? Cost analysis of external beam radiotherapy with carbon-ions, protons and photons.
Peeters A; Grutters JP; Pijls-Johannesma M; Reimoser S; De Ruysscher D; Severens JL; Joore MA; Lambin P
Radiother Oncol; 2010 Apr; 95(1):45-53. PubMed ID: 20106540
[TBL] [Abstract][Full Text] [Related]
38. Measurement of neutron dose equivalent and its dependence on beam configuration for a passive scattering proton delivery system.
Wang X; Sahoo N; Zhu RX; Zullo JR; Gillin MT
Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1563-70. PubMed ID: 20097484
[TBL] [Abstract][Full Text] [Related]
39. An experimental approach to improve the Monte Carlo modelling of offline PET/CT-imaging of positron emitters induced by scanned proton beams.
Bauer J; Unholtz D; Kurz C; Parodi K
Phys Med Biol; 2013 Aug; 58(15):5193-213. PubMed ID: 23835872
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
Lee EK; Fox T; Crocker I
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
